(Q24240332)

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

The need for epidemiologic studies of in-situ carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Towards optimal management of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Standard for the management of ductal carcinoma in situ of the breast (DCIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

Ductal Carcinoma in Situ of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

The quality and coping patterns of women's decision-making regarding breast cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

[Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021

Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000563.PUB6

7 January 2021